2012
DOI: 10.1186/1471-2431-12-57
|View full text |Cite
|
Sign up to set email alerts
|

Abernethy malformation: a case report

Abstract: BackgroundAbernethy malformation is a very rare congenital vascular malformation defined by diversion of portal blood away from liver. It is commonly associated with multiple congenital anomalies. We present a case of Abernethy malformation, without associated congenital anomalies from India.Case presentationA 5-year-old female child presented with short history of jaundice. A provisional diagnosis of acute viral hepatitis was made in view of clinical presentation and local endemicity of viral hepatitis A. Per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 19 publications
1
13
0
Order By: Relevance
“…In countries having neonatal screening programmes, some cases can be diagnosed by neonatal screening tests due to presence of galactosemia [11]. Many patients are diagnosed due to associated defects like heart disease, which are present in up-to 60 % of the patients [14].…”
Section: Discussionmentioning
confidence: 99%
“…In countries having neonatal screening programmes, some cases can be diagnosed by neonatal screening tests due to presence of galactosemia [11]. Many patients are diagnosed due to associated defects like heart disease, which are present in up-to 60 % of the patients [14].…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, with type 2 extrahepatic shunt, the connection with the systemic circulation occurs via collateral veins of a partially patent portal vein. Type 2 extrahepatic shunts have a better prognosis as only some of the blood from the portal circulation drain into the systemic circulation [14][15].…”
Section: Discussionmentioning
confidence: 99%
“…The absence of portal hepatotrophic factors (such as insulin and glucagon [ 27 , 28 ] and epidermal growth factor [ 29 ]) due to CAPV is probably a risk factor for the development of nodular liver lesions: benign tumors such as hepatocellular adenomas, focal nodular hyperplasia (FNH) [ 30 ], and nodular regenerative hyperplasia (NRH) [ 31 ], as well as malignant ones, such as hepatoblastoma [ 32 ], and hepatocellular carcinoma (HCC) [ 8 ]. Another possible explanation is that initially benign tumors reactively arise in the areas of the liver with poor perfusion, due to the lack of portal venous blood flow [ 33 ].…”
Section: Discussionmentioning
confidence: 99%